Clinical Trial Update: High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB [NA]

View source ↗

Summary

A clinical trial evaluating high-dose inhaled nitric oxide to prevent nosocomial pneumonia after cardiac surgery with cardiopulmonary bypass has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nosocomial Pneumonia

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences | Conditions: Nosocomial Pneumonia | NA | Status: COMPLETED